BioCircuit Technologies
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
BioCircuit Technologies - overview
Established
2016
Location
Atlanta, GA, US
Primary Industry
Medical Devices & Equipment
About
Based in Georgia, US, and founded in 2016 by James Ross BioCircuit Technologies operates as a healthcare company that provides developing tools for neural interfacing and tissue repair. In September 2022, BioCircuit Technologies raised USD 9 million in seed funding led by Masters Capital, with participation from Alsora Capital and GRA Venture Fund Other investors also participated in the round. As of October 2022, Michelle Jarrard is the Chief Operating Officer (CEO) of the company. BioCircuit Technologies monitors, control, and repair nerves consistently.
The company's devices use multi-electrode arrays and proprietary algorithms to repair peripheral nerves while also allowing clinicians to diagnose health conditions, track symptoms, and correctly select treatments for patients. The company intends to use the funds to commercialize its nerve repair device, Nerve Tape®, and develop its therapeutic device and a variety of other neurological conditions.
Current Investors
Masters Capital, GRA Venture Fund, Alsora Capital
Primary Industry
Medical Devices & Equipment
Sub Industries
Medical Supplies, Medical Equipment Distributors
Website
www.biocircuit.com
Verticals
HealthTech, Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
BioCircuit Technologies - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.